Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 60

1.

Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications?

Simone C, Ramirez A, Bucchia M, Rinchetti P, Rideout H, Papadimitriou D, Re DB, Corti S.

Cell Mol Life Sci. 2016 Mar;73(5):1003-20. doi: 10.1007/s00018-015-2106-9. Epub 2015 Dec 18. Review.

2.

Delay in Diagnosis of Spinal Muscular Atrophy: A Systematic Literature Review.

Lin CW, Kalb SJ, Yeh WS.

Pediatr Neurol. 2015 Oct;53(4):293-300. doi: 10.1016/j.pediatrneurol.2015.06.002. Epub 2015 Jun 10. Review.

3.

Advances and challenges in developing a therapy for spinal muscular atrophy.

Anderton RS, Mastaglia FL.

Expert Rev Neurother. 2015;15(8):895-908. doi: 10.1586/14737175.2015.1059757. Review.

PMID:
26200127
4.

Clinical and molecular features and therapeutic perspectives of spinal muscular atrophy with respiratory distress type 1.

Vanoli F, Rinchetti P, Porro F, Parente V, Corti S.

J Cell Mol Med. 2015 Sep;19(9):2058-66. doi: 10.1111/jcmm.12606. Epub 2015 Jun 20. Review.

5.

Disease mechanisms and therapeutic approaches in spinal muscular atrophy.

Tisdale S, Pellizzoni L.

J Neurosci. 2015 Jun 10;35(23):8691-700. doi: 10.1523/JNEUROSCI.0417-15.2015. Review.

6.

Spinal muscular atrophy--recent therapeutic advances for an old challenge.

Faravelli I, Nizzardo M, Comi GP, Corti S.

Nat Rev Neurol. 2015 Jun;11(6):351-9. doi: 10.1038/nrneurol.2015.77. Epub 2015 May 19. Review.

PMID:
25986506
7.

Newborn screening for spinal muscular atrophy: Anticipating an imminent need.

Phan HC, Taylor JL, Hannon H, Howell R.

Semin Perinatol. 2015 Apr;39(3):217-29. doi: 10.1053/j.semperi.2015.03.006. Review.

PMID:
25979781
8.

Moving towards treatments for spinal muscular atrophy: hopes and limits.

Wirth B, Barkats M, Martinat C, Sendtner M, Gillingwater TH.

Expert Opin Emerg Drugs. 2015 Sep;20(3):353-6. doi: 10.1517/14728214.2015.1041375. Epub 2015 Jul 3. Review.

PMID:
25920617
9.

Investigational therapies for the treatment of spinal muscular atrophy.

Kaczmarek A, Schneider S, Wirth B, Riessland M.

Expert Opin Investig Drugs. 2015;24(7):867-81. doi: 10.1517/13543784.2015.1038341. Epub 2015 Apr 24. Review.

PMID:
25911060
10.

Spinal Muscular Atrophy Therapeutics: Where do we Stand?

d'Ydewalle C, Sumner CJ.

Neurotherapeutics. 2015 Apr;12(2):303-16. doi: 10.1007/s13311-015-0337-y. Review.

11.

Pluripotent stem cell-based models of spinal muscular atrophy.

Frattini E, Ruggieri M, Salani S, Faravelli I, Zanetta C, Nizzardo M, Simone C, Magri F, Corti S.

Mol Cell Neurosci. 2015 Jan;64:44-50. doi: 10.1016/j.mcn.2014.12.005. Epub 2014 Dec 12. Review.

PMID:
25511182
12.

The Genetics of Spinal Muscular Atrophy: Progress and Challenges.

Farrar MA, Kiernan MC.

Neurotherapeutics. 2015 Apr;12(2):290-302. doi: 10.1007/s13311-014-0314-x. Review.

13.

Respiratory management of spinal muscular atrophy type 2.

Gormley MC.

J Neurosci Nurs. 2014 Dec;46(6):E33-41. doi: 10.1097/JNN.0000000000000080. Review.

PMID:
25365058
14.

Spinal muscular atrophy: diagnosis and management in a new therapeutic era.

Arnold WD, Kassar D, Kissel JT.

Muscle Nerve. 2015 Feb;51(2):157-67. doi: 10.1002/mus.24497. Epub 2014 Dec 16. Review.

15.

The wide spectrum of clinical phenotypes of spinal muscular atrophy with respiratory distress type 1: a systematic review.

Porro F, Rinchetti P, Magri F, Riboldi G, Nizzardo M, Simone C, Zanetta C, Faravelli I, Corti S.

J Neurol Sci. 2014 Nov 15;346(1-2):35-42. doi: 10.1016/j.jns.2014.09.010. Epub 2014 Sep 16. Review.

PMID:
25248952
16.

Assays for the identification and prioritization of drug candidates for spinal muscular atrophy.

Cherry JJ, Kobayashi DT, Lynes MM, Naryshkin NN, Tiziano FD, Zaworski PG, Rubin LL, Jarecki J.

Assay Drug Dev Technol. 2014 Aug;12(6):315-41. doi: 10.1089/adt.2014.587. Review.

17.

Molecular mechanisms and animal models of spinal muscular atrophy.

Edens BM, Ajroud-Driss S, Ma L, Ma YC.

Biochim Biophys Acta. 2015 Apr;1852(4):685-92. doi: 10.1016/j.bbadis.2014.07.024. Epub 2014 Aug 1. Review.

18.

Advances in therapeutic development for spinal muscular atrophy.

Howell MD, Singh NN, Singh RN.

Future Med Chem. 2014 Jun;6(9):1081-99. doi: 10.4155/fmc.14.63. Review.

19.

Spinal muscular atrophy: journeying from bench to bedside.

Awano T, Kim JK, Monani UR.

Neurotherapeutics. 2014 Oct;11(4):786-95. doi: 10.1007/s13311-014-0293-y. Review.

20.

Gene therapy: a promising approach to treating spinal muscular atrophy.

Mulcahy PJ, Iremonger K, Karyka E, Herranz-Martín S, Shum KT, Tam JK, Azzouz M.

Hum Gene Ther. 2014 Jul;25(7):575-86. doi: 10.1089/hum.2013.186. Epub 2014 Jun 27. Review.

PMID:
24845847
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk